Previous Article | Next Article 
Infection and Immunity, August 2002, p. 4591-4599, Vol. 70, No. 8
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.8.4591-4599.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Tumor Necrosis Factor Alpha Stimulates Killing of Mycobacterium tuberculosis by Human Neutrophils
Kevin O. Kisich,1* Michael Higgins,2 Gill Diamond,3 and Leonid Heifets2
Departments of Immunology,1
Medicine, National Jewish Medical and Research Center, Denver, Colorado 80206,2
Department of Anatomy, Cell Biology, and Injury Sciences, University of Medicine and Dentistry of New JerseyNewark, New Jersey 071033
Received 25 October 2001/
Returned for modification 7 January 2002/
Accepted 26 April 2002
The ability of human neutrophils to aid in defense against pulmonary infection with Mycobacterium tuberculosis is controversial. In this study, we have shown that neutrophils respond to and phagocytose M. tuberculosis in human lesions. Neutrophils from healthy individuals were able to kill significant fractions of an inoculum of M. tuberculosis within 1 h of phagocytosis, and this ability was enhanced by tumor necrosis factor alpha but not by gamma interferon. The mycobactericidal mechanism was nonoxidative, as inhibitors of reactive oxygen or reactive nitrogen intermediates did not interfere with killing. However, the mycobactericidal mechanism was associated with increased exposure of intracellular M. tuberculosis to neutrophil defensins. In vitro, human neutrophil peptides 1 to 3 were not able to kill the bacilli even at much higher levels. These studies support the concept that human neutrophils are directly involved in defense against infection with M. tuberculosis.
* Corresponding author. Mailing address: Department of Immunology, National Jewish Medical and Research Center, and University of Colorado Health Sciences Center, 1400 Jackson St., Denver, CO 80206. Phone: (303) 398-1623. Fax: (303) 398-1225. E-mail:
kisichk{at}njc.org.
Editor: S. H. E. Kaufmann
Infection and Immunity, August 2002, p. 4591-4599, Vol. 70, No. 8
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.8.4591-4599.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Driss, V., Legrand, F., Hermann, E., Loiseau, S., Guerardel, Y., Kremer, L., Adam, E., Woerly, G., Dombrowicz, D., Capron, M.
(2009). TLR2-dependent eosinophil interactions with mycobacteria: role of {alpha}-defensins. Blood
113: 3235-3244
[Abstract]
[Full Text]
-
Sawant, K. V., McMurray, D. N.
(2007). Guinea Pig Neutrophils Infected with Mycobacterium tuberculosis Produce Cytokines Which Activate Alveolar Macrophages in Noncontact Cultures. Infect. Immun.
75: 1870-1877
[Abstract]
[Full Text]
-
Umemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., Matsuzaki, G.
(2007). IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guerin Infection. J. Immunol.
178: 3786-3796
[Abstract]
[Full Text]
-
Tan, B. H., Meinken, C., Bastian, M., Bruns, H., Legaspi, A., Ochoa, M. T., Krutzik, S. R., Bloom, B. R., Ganz, T., Modlin, R. L., Stenger, S.
(2006). Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens. J. Immunol.
177: 1864-1871
[Abstract]
[Full Text]
-
Janulionis, E., Sofer, C., Schwander, S. K., Nevels, D., Kreiswirth, B., Shashkina, E., Wallis, R. S.
(2005). Survival and Replication of Clinical Mycobacterium tuberculosis Isolates in the Context of Human Innate Immunity. Infect. Immun.
73: 2595-2601
[Abstract]
[Full Text]
-
Eruslanov, E. B., Lyadova, I. V., Kondratieva, T. K., Majorov, K. B., Scheglov, I. V., Orlova, M. O., Apt, A. S.
(2005). Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice. Infect. Immun.
73: 1744-1753
[Abstract]
[Full Text]
-
Giles, J. T., Bathon, J. M.
(2004). Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases. J Intensive Care Med
19: 320-334
[Abstract]